Registry Study on Biological Disease Profile and Clinical Outcome in Patients with Newly Diagnosed Breast or Ovarian CancerThe BRandO Biology and Outcome (BiO)-Project

Recruiting

• Conditions: C50; C56; Malignant neoplasm of breast; Malignant neoplasm of ovary

• Registration Number: DRKS00009989
• Lead Sponsor: niversitätsklinikum UlmKlinik für Frauenheilkunde und Geburtshilfe

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

Patients with primary newly diagnosed of breast or ovarian cancer
Age = 18 years. There is no upper age limit.
signed informed consent

Exclusion Criteria

Severe neurological or psychiatric disorder interfering with ability to give an informed consent
No consent for registration, storage and processing of the individual disease characteristics and course

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Objectives:<br>- Incidence of different molecular aberrations<br>- To document treatment decisions (intensive, non-intensive, investigational)<br>- Progression-free survival (PFS)<br>- Overall survival (OS)